Journal of Hepatology
Volume 51, Issue 6 , Pages 1010-1020, December 2009

The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression

  • Ana Pardo-Saganta

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
  • ,
  • Maria Ujue Latasa

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
  • ,
  • Josefa Castillo

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
  • ,
  • Laura Alvarez-Asiain

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
  • ,
  • María J. Perugorría

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
  • ,
  • Pablo Sarobe

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
  • ,
  • Carlos M. Rodriguez-Ortigosa

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
  • ,
  • Jesús Prieto

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • CiberEhd, Clínica Universidad de Navarra, Pamplona, Spain
  • ,
  • Carmen Berasain

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
  • ,
  • Mónica Santamaría

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • Corresponding Author InformationCorresponding authors. Tel.: +34 948194700; fax: +34 948194717. (M.A. Avila)
  • ,
  • Matías A. Avila

      Affiliations

    • Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII n. 55, 31008 Pamplona, Spain
    • Corresponding Author InformationCorresponding authors. Tel.: +34 948194700; fax: +34 948194717. (M.A. Avila)

Received 16 April 2009; received in revised form 9 June 2009; accepted 25 June 2009. published online 14 September 2009.

Associate Editor: C. Trautwein

Background/Aims

The modulation of the hepatic acute-phase reaction (APR) that occurs during inflammation and liver regeneration is important for allowing normal hepatocellular proliferation and the restoration of homeostasis. Activation of acute-phase protein (APP) gene expression by interleukin-6 (IL-6)-type cytokines is thought to be counteracted by growth factors released during hepatic inflammation and regeneration. The epidermal growth factor receptor (EGFR) ligand amphiregulin (AR) is readily induced by inflammatory signals and plays a nonredundant protective role during liver injury. In this paper, we investigated the role of AR as a modulator of liver APP gene expression.

Methods

Expression of APP genes was measured in the livers of AR+/+ and AR−/−mice during inflammation and regeneration and in cultured liver cells treated with AR and oncostatin M (OSM). Crosstalk between AR and OSM signalling was studied.

Results

APP genes were overexpressed in the livers of AR−/− mice during inflammation and hepatocellular regeneration. In cultured AR-null hepatocytes and human hepatocellular carcinoma (HCC) cells after AR knockdown, APP gene expression is enhanced. AR counteracts OSM-triggered signal transducer and activator of transcription 3 signalling in hepatocytes and attenuates APP gene transcription.

Conclusions

Our data support the relevance of EGFR-mediated signalling in the modulation of cytokine-activated pathways. We have identified AR as a key regulator of hepatic APP gene expression during inflammation and liver regeneration.

Abbreviations: APR, acute-phase reaction, APP, acute-phase protein, IL, interleukin, EGFR, epidermal growth factor receptor, AR, amphiregulin, OSM, oncostatin M, STAT, signal transducer and activator of transcription, TNF, tumour necrosis factor, JAK, Janus-activated kinase, TGF, transforming growth factor, HB-EGF, heparin-binding EGF-like growth factor, BTC, betacellulin, EREG, epiregulin, LPS, lipopolysaccharide, MEK1, extracellular regulated kinase kinase 1, ActD, actinomycin D, α1-ACT, α1-antichymotrypsin, SAA, serum amyloid A, AGP2, α1-acid glycoprotein 2, ERK, extracellular regulated kinase, SHP2, Src homology 2 domain-containing tyrosine phosphatase, SOCS, suppressor of cytokine signalling, siRNA, short interfering RNA, ChIP, chromatin immunoprecipitation, PH, partial hepatectomy

Keywords: Acute-phase proteins, Amphiregulin, Oncostatin, Liver regeneration

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors who have taken part in this study declared that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.

PII: S0168-8278(09)00582-0

doi:10.1016/j.jhep.2009.06.030

Journal of Hepatology
Volume 51, Issue 6 , Pages 1010-1020, December 2009